1. Home
  2. ANVS vs ZDGE Comparison

ANVS vs ZDGE Comparison

Compare ANVS & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • ZDGE
  • Stock Information
  • Founded
  • ANVS 2008
  • ZDGE 2008
  • Country
  • ANVS United States
  • ZDGE United States
  • Employees
  • ANVS N/A
  • ZDGE N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • ZDGE Computer Software: Prepackaged Software
  • Sector
  • ANVS Health Care
  • ZDGE Technology
  • Exchange
  • ANVS Nasdaq
  • ZDGE Nasdaq
  • Market Cap
  • ANVS 55.5M
  • ZDGE 45.4M
  • IPO Year
  • ANVS 2020
  • ZDGE N/A
  • Fundamental
  • Price
  • ANVS $2.74
  • ZDGE $3.37
  • Analyst Decision
  • ANVS Strong Buy
  • ZDGE
  • Analyst Count
  • ANVS 4
  • ZDGE 0
  • Target Price
  • ANVS $18.00
  • ZDGE N/A
  • AVG Volume (30 Days)
  • ANVS 277.6K
  • ZDGE 53.9K
  • Earning Date
  • ANVS 08-12-2025
  • ZDGE 06-12-2025
  • Dividend Yield
  • ANVS N/A
  • ZDGE N/A
  • EPS Growth
  • ANVS N/A
  • ZDGE N/A
  • EPS
  • ANVS N/A
  • ZDGE N/A
  • Revenue
  • ANVS N/A
  • ZDGE $29,511,000.00
  • Revenue This Year
  • ANVS N/A
  • ZDGE N/A
  • Revenue Next Year
  • ANVS N/A
  • ZDGE $2.95
  • P/E Ratio
  • ANVS N/A
  • ZDGE N/A
  • Revenue Growth
  • ANVS N/A
  • ZDGE 1.27
  • 52 Week Low
  • ANVS $1.11
  • ZDGE $1.73
  • 52 Week High
  • ANVS $10.54
  • ZDGE $4.89
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 52.55
  • ZDGE 37.54
  • Support Level
  • ANVS $2.58
  • ZDGE $3.31
  • Resistance Level
  • ANVS $2.94
  • ZDGE $3.65
  • Average True Range (ATR)
  • ANVS 0.21
  • ZDGE 0.23
  • MACD
  • ANVS -0.00
  • ZDGE -0.08
  • Stochastic Oscillator
  • ANVS 64.41
  • ZDGE 5.31

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About ZDGE Zedge Inc. Class B

Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.

Share on Social Networks: